LF
NBIX icon

Lee Financial’s Neurocrine Biosciences NBIX Stock Holding History

Lee Financial’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-150
Closed -$19.8K – 583
2023
Q4 		$19.8K Hold
150
– – ﹤0.01% 322
2023
Q3 		$16.9K Hold
150
– – ﹤0.01% 328
2023
Q2 		$14.1K Hold
150
– – ﹤0.01% 357
2023
Q1 		$15.2K Sell
150
-10
-6% -$1.04K ﹤0.01% 354
2022
Q4 		$19.1K Hold
160
– – ﹤0.01% 347
2022
Q3 		$17K Sell
160
-47
-23% -$4.77K ﹤0.01% 352
2022
Q2 		$20K Buy
207
+2
+1% +$185 ﹤0.01% 335
2022
Q1 		$19K Buy
205
+21
+11% +$1.78K ﹤0.01% 349
2021
Q4 		$16K Buy
184
+24
+15% +$2.21K ﹤0.01% 409
2021
Q3 		$15K Hold
160
– – ﹤0.01% 372
2021
Q2 		$16K Buy
160
+20
+14% +$1.92K ﹤0.01% 347
2021
Q1 		$14K Hold
140
– – ﹤0.01% 355
2020
Q4 		$13K Hold
140
– – ﹤0.01% 345
2020
Q3 		$13K Hold
140
– – ﹤0.01% 361
2020
Q2 		$17K Hold
140
– – ﹤0.01% 297
2020
Q1 		$12K Buy
140
+25
+22% +$2.45K ﹤0.01% 272
2019
Q4 		$12K Hold
115
– – ﹤0.01% 318
2019
Q3 		$10K Buy
115
+10
+10% +$934 ﹤0.01% 343
2019
Q2 		$9K Hold
105
– – ﹤0.01% 369
2019
Q1 		$9K Hold
105
– – ﹤0.01% 357
2018
Q4 		$7K Buy
+105
New +$10.1K ﹤0.01% 334

Other funds holding NBIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Lee Financial's NBIX Position: Q1 2024 in Review

Lee Financial sold out of Neurocrine Biosciences (NBIX) in Q1 2024, closing a stake of 150 shares — an estimated $19.8K sold.

Lee Financial first reported a position in NBIX in Q4 2018 and held it in 21 quarters. The position peaked at $20K in Q2 2022. 589 funds tracked by Wall St. Rank hold NBIX as of Q1 2024.

  • Lee Financial reported no remaining Neurocrine Biosciences position as of Q1 2024 after selling out during the quarter.
  • Lee Financial sold 150 Neurocrine Biosciences shares in Q1 2024, an estimated $19.8K.
  • Lee Financial first reported a position in Neurocrine Biosciences in Q4 2018 and held it in 21 quarters.
  • Lee Financial's Neurocrine Biosciences position peaked at $20K in Q2 2022.
  • 589 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q1 2024.

Based on Lee Financial's 13F filing for Q1 2024, filed 15 May 2024.